FR2702660B1 - Compositions thérapeutiques stabilisées et leur procédé de préparation. - Google Patents

Compositions thérapeutiques stabilisées et leur procédé de préparation.

Info

Publication number
FR2702660B1
FR2702660B1 FR9303060A FR9303060A FR2702660B1 FR 2702660 B1 FR2702660 B1 FR 2702660B1 FR 9303060 A FR9303060 A FR 9303060A FR 9303060 A FR9303060 A FR 9303060A FR 2702660 B1 FR2702660 B1 FR 2702660B1
Authority
FR
France
Prior art keywords
preparation
therapeutic compositions
stabilized therapeutic
stabilized
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9303060A
Other languages
English (en)
Other versions
FR2702660A1 (fr
Inventor
Karl Simpson
Radu Crainic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9303060A priority Critical patent/FR2702660B1/fr
Priority to EP94910435A priority patent/EP0689457A1/fr
Priority to AU62851/94A priority patent/AU6285194A/en
Priority to CN94191508A priority patent/CN1119414A/zh
Priority to CA002158140A priority patent/CA2158140A1/fr
Priority to PCT/FR1994/000296 priority patent/WO1994021298A1/fr
Publication of FR2702660A1 publication Critical patent/FR2702660A1/fr
Application granted granted Critical
Publication of FR2702660B1 publication Critical patent/FR2702660B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR9303060A 1993-03-17 1993-03-17 Compositions thérapeutiques stabilisées et leur procédé de préparation. Expired - Fee Related FR2702660B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9303060A FR2702660B1 (fr) 1993-03-17 1993-03-17 Compositions thérapeutiques stabilisées et leur procédé de préparation.
EP94910435A EP0689457A1 (fr) 1993-03-17 1994-03-17 Compositions pharmaceutiques stabilisees et leurs procedes de preparation
AU62851/94A AU6285194A (en) 1993-03-17 1994-03-17 Stabilised pharmaceutical compositions and methods for preparing same
CN94191508A CN1119414A (zh) 1993-03-17 1994-03-17 稳定化的药物组合物及其制备方法
CA002158140A CA2158140A1 (fr) 1993-03-17 1994-03-17 Compositions pharmaceutiques stabilisees et leurs procedes de preparation
PCT/FR1994/000296 WO1994021298A1 (fr) 1993-03-17 1994-03-17 Compositions pharmaceutiques stabilisees et leurs procedes de preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303060A FR2702660B1 (fr) 1993-03-17 1993-03-17 Compositions thérapeutiques stabilisées et leur procédé de préparation.

Publications (2)

Publication Number Publication Date
FR2702660A1 FR2702660A1 (fr) 1994-09-23
FR2702660B1 true FR2702660B1 (fr) 1995-05-24

Family

ID=9445053

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9303060A Expired - Fee Related FR2702660B1 (fr) 1993-03-17 1993-03-17 Compositions thérapeutiques stabilisées et leur procédé de préparation.

Country Status (6)

Country Link
EP (1) EP0689457A1 (fr)
CN (1) CN1119414A (fr)
AU (1) AU6285194A (fr)
CA (1) CA2158140A1 (fr)
FR (1) FR2702660B1 (fr)
WO (1) WO1994021298A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2293100A (en) * 1994-09-15 1996-03-20 Medeva Europ Ltd Pharmaceutical compositions with deuterium oxide
WO2003018614A1 (fr) * 2001-08-24 2003-03-06 Wako Pure Chemical Industries, Ltd. Procede de stabilisation de l'alteration d'une substance dans un milieu aqueux
US8734525B2 (en) 2003-12-31 2014-05-27 Warsaw Orthopedic, Inc. Osteoinductive demineralized cancellous bone
US8328876B2 (en) 2003-12-31 2012-12-11 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
EP1708651A4 (fr) * 2004-01-27 2011-11-02 Osteotech Inc Greffe osseuse stabilisee
EP1942960B1 (fr) 2005-11-01 2012-08-29 Warsaw Orthopedic, Inc. Méthodes pour produire des compositions de matrice d'os
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
EP3207948B1 (fr) 2007-06-15 2020-02-26 Warsaw Orthopedic, Inc. Compositions de matrice osseuse et méthodes
WO2009009688A1 (fr) 2007-07-10 2009-01-15 Osteotech, Inc. Système d'administration
US9101475B2 (en) 2009-02-12 2015-08-11 Warsaw Orthopedic, Inc. Segmented delivery system
FR2960781B1 (fr) 2010-06-07 2013-11-22 Sanofi Pasteur Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue
WO2016172712A2 (fr) 2015-04-23 2016-10-27 Sydnexis, Inc. Composition ophtalmique
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
CN118453493A (zh) 2015-05-29 2024-08-09 西德奈克西斯公司 D2o稳定化的药物制剂
CN117752780A (zh) * 2017-12-07 2024-03-26 默沙东有限责任公司 登革病毒疫苗组合物的制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability

Also Published As

Publication number Publication date
AU6285194A (en) 1994-10-11
WO1994021298A1 (fr) 1994-09-29
FR2702660A1 (fr) 1994-09-23
EP0689457A1 (fr) 1996-01-03
CA2158140A1 (fr) 1994-09-29
CN1119414A (zh) 1996-03-27

Similar Documents

Publication Publication Date Title
FR2696176B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
DZ2045A1 (fr) Amides thérapeutiques, procédé pour leur préparation et compositions les contenant.
FR2702660B1 (fr) Compositions thérapeutiques stabilisées et leur procédé de préparation.
FR2707087B1 (fr) Nouveau procédé de préparation de l'ergothionéine.
FR2696744B1 (fr) Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
FR2708467B1 (fr) Préparations d'immunoglobulines stabilisées et procédé pour leur préparation.
FR2705095B1 (fr) Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2720397B1 (fr) Nouveaux oxathiolanes, leur procédé de préparation et les compositions pharmaceutiques qui en renferment.
OA09840A (fr) dérivés de pipéridine, leur préparation et leur application en thérapeutique
DZ2658A1 (fr) Formulations nouvelles de paroxétine et procédé pour leur préparation.
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
FR2695645B1 (fr) Procédé de préparation de polyaminoborazines.
FR2697830B1 (fr) Procédé de préparation de coulis injectable.
FR2697250B1 (fr) Dérivés de beta,beta-diméthyl-4-pipéridineéthanol et de 1,2,3,6-tétrahydro-beta,beta-diméthyl-4-pyridineéthanol, leur procédé de préparation et leur utilisation en thérapeutique.
FR2704857B1 (fr) Nouvelles benzodioxines substituées, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2705672B1 (fr) Procédé de préparation de nitrophénols.
FR2693197B1 (fr) Nouveaux dérivés de quinoléine, leur procédé de préparation et leur application thérapeutique.
FR2700538B1 (fr) Procédé de préparation de 2-méthyl-3-aminobenzotrifluorure.
FR2719580B1 (fr) Procédé de préparation d'octadiénols.
FR2694933B1 (fr) Procédé de préparation d'isocyanates d'acyle.
FR2708928B1 (fr) Procédé de préparation de 2-halogéno-éthyl-malonates de dialkyle.
FR2695388B1 (fr) Dérivés de 1,3,4-benzotriazépin-5(4H)-one et procédé pour leur préparation.
FR2699919B1 (fr) Dérivés d'imidazole, leur procédé de préparation et leur application en thérapeutique.
FR2711137B1 (fr) Allylaminoesters, leur procédé de préparation et leur application en thérapeutique.
OA09881A (fr) Nouvelles quinolones fluorées, leur procédé de préparation et les compositions pharmaceutiques en renfermant

Legal Events

Date Code Title Description
RM Correction of a material error
TP Transmission of property
ST Notification of lapse